barbital , phenobarbital , ethanol , diazepam , nitrazepam , meprobamate , methaqualone , chlorpromazine , diphenylhydantoin , mephenesin , reserpine and clonidine were cross-administered to evaluate the mode of suppression of withdrawal signs and cross-physical dependence liability .
C0220825
evaluate
C0031809
physical